China Journal of Leprosy and Skin Diseases ›› 2019, Vol. 35 ›› Issue (12): 765-768.doi: 10.12144/zgmfskin201912765

Previous Articles    

Update of antidepressants in the treatment of postherpetic neuralgia

ZHOU Hucheng1,2, LUO Fenglin1,2, XU Hui1,2, LI Yumei1,2   

  1. 1. The Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China; 
    2. Jiangsu University Institute of Regenerative Medicine, Zhenjiang 212001, China
  • Online:2019-12-15 Published:2019-12-25
  • Contact: LI Yumei, E-mail: yumeili@ujs.edu.cn

Abstract: Postherpetic neuralgia (PHN) is a kind of neuropathic pain, which often brings huge physical and mental burden to patients and seriously affects the social function and quality of life. At present, there are various analgesic schemes for the treatment of PHN, and antidepressants have been recognized as first-line medications for treatment. The effectiveness of tricyclic antidepressants in treating PHN has been verified, while serotonin norepinephrine reuptake inhibitors need further validation. The update of antidepressants in the treatment of postherpetic neuralgia is summarized in this paper. We propose combination therapy in order to improve analgesic effect and reduce the dose of monotherapy and adverse reactions.

Key words: antidepressants, postherpetic neuralgia, combination therapy